Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD

Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD

BackgroundSyndrome of inappropriate antidiuresis (SIAD) is one of the most frequent causes of euvolemic hyponatremia (serum sodium levels < 135 mEq/L) and it represents more than 35% of hyponatremia cases in hospitalized patients. It is characterized by an inappropriate vasopressin (AVP)/anti...

Full description

Bibliographic Details
Main Authors:	Anna Arecco, Davide Demontis, Leonardo Della Sala, Natale Musso, Stefano Gay, Mara Boschetti, Diego Ferone, Federico Gatto
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Endocrinology
Subjects:	syndrome of inappropriate antidiuresis hyponatremia vasopressin receptor antagonists tolvaptan sodium corpus callosum agenesis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1309657/full

Similar Items

Hyponatremia and Cancer: From Bedside to Benchside
by: Benedetta Fibbi, et al.
Published: (2023-02-01)

Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
by: Rita Indirli, et al.
Published: (2021-05-01)

Safety and Efficacy of Vaptans in the Treatment of Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): A Systematic Review and Meta-Analysis
by: Pajaree Krisanapan, et al.
Published: (2023-08-01)

Use of 'Vaptans' in treatment of hyponatremia
by: Aslı Tanındı, et al.
Published: (2015-04-01)

Effectiveness of Tolvaptan Treatment in Hyponatremic Patients
by: Mehmet Fethullah Aydın, et al.
Published: (2020-04-01)

The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia
by: Fatih Kahraman, et al.
Published: (2015-04-01)

Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality
by: Masahiko Tosaka, et al.
Published: (2022-10-01)

Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
by: Annabelle M. Warren, et al.
Published: (2022-04-01)

COVID-19 and hyponatremia
by: LIANG Si-yu, CHEN Shi, PAN Hui, JIAJUE Rui-zhi, ZHU Hui-juan
Published: (2021-12-01)

A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia
by: Jobin Kunjumon Vilapurathu, et al.
Published: (2014-01-01)

Acute and Chronic Hyponatremia
by: Murad Kheetan, et al.
Published: (2021-08-01)

Hyponatremia Promotes Cancer Growth in a Murine Xenograft Model of Neuroblastoma
by: Giada Marroncini, et al.
Published: (2023-11-01)

Tolvaptan
by: Bharath Rangarajan, et al.
Published: (2014-01-01)

Short term efficacy and safety of low dose tolvaptan in patients with acute decompensated heart failure with hyponatremia: a prospective observational pilot study from a single center in South India
by: Soumya Patra, et al.
Published: (2014-01-01)

Case Report: Long-Term Tolvaptan Treatment in a Child With SIADH and Suprasellar Arachnoid Cyst
by: Andrea Puma, et al.
Published: (2021-07-01)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
by: Shuzhen Wang, et al.
Published: (2018-09-01)

Treatment of Hyponatremia with Tolvaptan in a Patient after Neurosurgical Treatment of a Pituitary Tumor: Case Report and Review of Literature
by: Shinya Ichimura, et al.
Published: (2015-10-01)

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
by: N. O’Connor-Byrne, et al.
Published: (2019-02-01)

The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia
by: Sua Kim, et al.
Published: (2021-12-01)

Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery
by: Agathoklis Efthymiadis, et al.
Published: (2024-01-01)

Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives
by: Thajudeen B, et al.
Published: (2016-08-01)

Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer
by: D Mc Donald, et al.
Published: (2023-01-01)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
by: Tatsufumi Oka, et al.
Published: (2021-12-01)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
by: Tien M.H. Ng, et al.
Published: (2020-08-01)

Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial
by: Elangovan Shanmugam, et al.
Published: (2016-04-01)

Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey
by: Saim Sağ, et al.
Published: (2017-07-01)

Tolvaptan: A Novel Diuretic in Heart Failure Management
by: Hilman Zulkifli Amin, et al.
Published: (2016-07-01)

Hypertonic saline versus fluid restriction: The pitfalls in managing acute hyponatremia in a patient with long‐standing spinal cord injury
by: Vaios Koutroukas, et al.
Published: (2022-12-01)

Pathophysiology of Drug-Induced Hyponatremia
by: Gheun-Ho Kim
Published: (2022-09-01)

Hyponatremia: An Unusual Presentation in a Neonate With Chromosome 1q21.1 Deletion Syndrome
by: Bakri Alzarka, et al.
Published: (2018-10-01)

Inappropriate Arginine Vasopressin Levels and Hyponatremia Associated with Cyclic Vomiting Syndrome
by: Anders Breinbjerg, et al.
Published: (2015-01-01)

Hyponatremia: a case report of SIAD
by: Letizia Canu, et al.
Published: (2013-06-01)

Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma
by: Fatih Gürbüz, et al.
Published: (2019-06-01)

The role of hyponatremia in preeclampsia
by: Erdinc Saridogan, et al.
Published: (2017-09-01)

Hyponatremia: A clinical approach
by: D Yu Shchekochikhin, et al.
Published: (2017-08-01)

Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01)

Efficacy of oral tolvaptan versus 3% hypertonic saline for correction of hyponatraemia in post-operative patients
by: Pulak Tosh, et al.
Published: (2017-01-01)

Hyponatremia in stroke
by: Sheikh Saleem, et al.
Published: (2014-01-01)

Preliminary Report of Intravenous Tolvaptan Sodium Phosphate (Samtas<sup>®</sup>) Treatment in Decompensated Heart Failure
by: Makiko Nakamura, et al.
Published: (2024-01-01)

An Approach to Hyponatremia
by: Kaylie Schachter
Published: (2021-05-01)